In this study, we explored the underlying biological features of overexpressed ESM1 in human CSCC via the VEGFα/ERK signaling pathway to augment endothelial cell proliferation and tumor angiogenesis, suggesting that ESM1 may serve as a promising prognostic biomarker or therapeutic target for CSCC. Here, VEGFA is linked to neoplasm.